An arousal-first approach to erectile dysfunction
Most ED pills work on blood vessels. Apomorphine is different — a centrally-acting dopamine agonist that switches on the brain's arousal circuitry, then lets the body respond.
The short version
Erections begin in the brain. Apomorphine is one of the few well-studied compounds that acts there directly — a genuinely different mechanism from the PDE5 inhibitors most people know.
Explore
Three ways into the subject — the biology, the products, and the clinical case.
Apomorphine is a non-selective dopamine agonist. In the hypothalamus it mimics dopamine at D1 and D2 receptors, triggering the neural cascade that begins an erection — the reason it works "upstream" of the bloodstream.
Read the science →Apomorphine reaches men today mostly through compounded sublingual formulas — some pairing it with PDE5 inhibitors for dual central-and-peripheral action.3 See how the leading options compare.
View the rankings →Decades of trials — plus a 2006 review naming sublingual apomorphine a viable first-line option — make the clinical case. Here's what the evidence shows on efficacy, dosing, and who benefits most.
See the evidence →The evidence
Pooled from placebo-controlled trials and a comparative review of apomorphine formulations for ED.
The sublingual route bypasses first-pass liver metabolism, giving a favorable therapeutic index at approved doses. The most common side effects reported in trials were nausea, headache, and dizziness, generally mild and dose-related. Because apomorphine can lower blood pressure, clinicians advise caution with antihypertensive medicines and monitoring in men with cardiovascular risk.14
Its central action is also why apomorphine has drawn interest beyond ED — the same dopaminergic activity underlies its long-standing use in Parkinson's disease.2
Quick answers
Viagra and other PDE5 inhibitors work on blood vessels in the penis to improve blood flow. Apomorphine works in the brain — it activates dopamine receptors that begin the arousal signal. Different mechanism, different starting point. In head-to-head studies sildenafil generally produced stronger erectile responses, but apomorphine offers a central option for men whose ED has a neurological or psychogenic component.2
No — despite the name, apomorphine is not an opioid and does not act on opioid receptors or cause opioid effects. It was historically derived from morphine chemically, but pharmacologically it is a dopamine agonist.2
Taken sublingually (under the tongue), apomorphine is absorbed quickly and reaches the brain within minutes. In clinical trials the median time to an erection with sexual stimulation was about 16–23 minutes, and many product guides cite roughly 15–20 minutes.4
Not in the United States. Apomorphine is FDA-approved for Parkinson's disease, and the branded sublingual ED tablets (Uprima/Ixense) were approved in Europe but are no longer marketed. Where it is used for ED, it is typically compounded and prescribed off-label by a clinician.2
Cited research
